BioPharma Market Update: GSK’s Strategic Pivot to China, Biotech IPOs Reach Pandemic-Era Heights, and Scholar Rock Navigates Post-Approval Volatility
The biopharmaceutical landscape is currently undergoing a dynamic transformation, characterized by shifting geopolitical alliances, a...
